Effect of estrogen plus progestin on stroke in postmenopausal women: the Women's Health Initiative: a randomized trial.
By S. Wassertheil-Smoller, S. Hendrix, M. Limacher, G. Heiss, Charles L. Kooperberg, A. E. Baird, Theodore A. Kotchen, J. D. Curb, Henry R. Black, J. Rossouw and 5 more. Journal of the American Medical Association (JAMA), 2003
1,198 citations recorded by the source corpus.
Subfields: Endocrinology, Diabetes and Metabolism
View Paper: https://www.semanticscholar.org/paper/140d3fb193c2aab7a879a083ec2da3843a451849
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Endocrinology, Diabetes and Metabolism
Citations in the corpus
- The Japanese Society of Hypertension Guidelines for the Management of Hypertension (JSH 2019) (2019, background): “In cases treated with estrogen or progesterone, mild elevation of SBP has been reported [1402].”
- Risk of complications of pregnancy in women with type 1 diabetes: nationwide prospective study in the Netherlands (2004, background): “However, at these ages 5 years’ use of hormone therapy would lead to a greater increase in the absolute incidence of breast cancer and of stroke than any reduction in the absolute incidence of hip fracture.(1,3,21,22) No data were available for women older than 70 years.”
- From cancer patient to cancer survivor : lost in transition (2006, background): “There has been considerable controversy regarding the use of HRT since the publication of results of the Women’s Health Initiative study in 2003 (Wassertheil-Smoller et al., 2003).”
- European guidance for the diagnosis and management of osteoporosis in postmenopausal women (2008, background): “In this large cohort of postmenopausal women in their 60s, the combined use of conjugated oestrogen and medroxyprogesterone acetate was associated with a 30 % increased risk of coronary heart disease (CHD) and breast cancer, and with a 40 % increase in stroke [232–234].”
- National cross sectional survey to determine whether the decision to delivery interval is critical in emergency caesarean section (2004, result): “The observed adverse effect of CEE on the risk of stroke is consistent with the risks reported by the WHI and HERS estrogen plus progestin trials.(27,28) In addition, the use of estradiol in women after ischemic stroke resulted in no change in mortality but a higher rate of recurrent nonfatal stroke”